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Abstract: To promote sustainable development, the smart city implies a global vision that merges
artificial intelligence, big data, decision making, information and communication technology (ICT),
and the internet-of-things (IoT). The ageing issue is an aspect that researchers, companies and
government should devote efforts in developing smart healthcare innovative technology and
applications. In this paper, the topic of disease diagnosis in smart healthcare is reviewed. Typical
emerging optimization algorithms and machine learning algorithms are summarized. Evolutionary
optimization, stochastic optimization and combinatorial optimization are covered. Owning to the
fact that there are plenty of applications in healthcare, four applications in the field of diseases
diagnosis (which also list in the top 10 causes of global death in 2015), namely cardiovascular diseases,
diabetes mellitus, Alzheimer’s disease and other forms of dementia, and tuberculosis, are considered.
In addition, challenges in the deployment of disease diagnosis in healthcare have been discussed.
Keywords: automation; computational intelligence; data analysis; data mining; disease diagnosis;
healthcare; smart living; smart city; social progress; sustainability
1. Introduction
There are different definitions and interpretations of a “smart city”. In the research area, the
smart city is viewed as having characteristics such as: (i) adopting information and communication
technology (ICT) to solve the daily life problems in governance, environment, economy, healthcare, etc.;
(ii) improving the quality of life of human beings; (iii) using computational intelligence to address
real-world issues by mathematical formulations and machine learning algorithms; and (iv) distributing
the workload to computers, robots and machines [1].
Human health is wealth; there is nothing more valuable than good health. Researchers have
devoted vast efforts in proposing new policies, algorithms, systems and architectures for healthcare.
Healthcare is defined as the amelioration of health through the prevention, treatment and examination
of physical damage, mental damage, illness, injury and disease.
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Today’s world is experiencing three challenges in healthcare: shortage of medical personnel,
ageing and high total expenditure on healthcare. Reports from the World Health Organization (WHO)
stated that the global need and the factual amount of health workforce were 60.4 million and 43 million,
respectively, in 2013 [2]. These figures will increase to 81.8 million and 67.3 million, respectively, by
2030. Therefore, the shortage of medical personnel is unsolved and remains serious.
From 2000 to 2050, the percentage of world population over 60 years will double (from 11% to
22%) [3]. One of the major reasons is that the birth rate has remained low in past and it is estimated to
keep low in the coming decades. The older the person, the higher is the chance of getting diseases,
illnesses and requiring long-term caring and medical treatments. Consequently, more human resources
and expenditures should be allocated to the age group of 60 or above.
The total expenditure on healthcare has occupied a significant portion as a percentage of the
gross domestic product (GDP). The survey from WHO concluded that the corresponding figures in
China, U.S.A., Canada, Brazil, Russian Federation, India, and Australia are 5.6%, 17.1%, 10.5%, 8.3%,
7.1%, 4.7%, and 9.4%, respectively [4]. Attributed to ageing, these figures will be increased in the
coming decades.
It is good news that, with the rapid increase in computation power and availability of health
data, healthcare applications can include artificial intelligence and thus become smart healthcare.
This can certainly help solving some of the aforementioned challenges in healthcare. In addition,
it will facilitate sustainable development [5–7]. Healthcare sustainability aims at simultaneously
optimizing the financial and social impacts of the health service, without compromising the health of
our patients and our ability to provide healthcare in the future. In fact, the inadequate amounts of
medical personnel and increase portion of elderly increase government expenditure and lower the
social productivity.
Optimization algorithms and machine learning algorithms are core tools that can benefit
healthcare applications. Three kinds of optimization algorithms, evolutionary [8–17], stochastic [18–29]
and combinatorial optimization [30–38] will be addressed. For machine learning algorithms,
the discussion is based on un-supervised learning [39–49], supervised learning [50–70] and
semi-supervised learning [71–81]. The technical content in terms of mathematical formulation of these
algorithms will not be discussed in this review, but it will illustrate examples to reveal the potential
opportunities between optimization/machine learning algorithms and healthcare application.
Due to the multitude of smart healthcare applications, only four applications in the field of
diseases diagnosis, cardiovascular diseases [82–99], diabetes mellitus [100–112], Alzheimer’s disease
and other forms of dementias [113–126], and tuberculosis [127–140] are considered. These are listed
on the top 10 causes of annual global death. The applications of various disease diagnosis in smart
healthcare are related to automated decision making. If the performance of the classification algorithm
is good in terms of overall accuracy and testing time, it may ultimately replace the role of medical
doctors in disease diagnosis (and medical doctors can devote their time majorly in complicated
surgery). The second case is that the classification algorithm will be utilized as rapid test (fair overall
accuracy and rapid decision) for low-cost and large-scale screening.
This paper is organized as follows. Section 2 discusses the emerging optimization algorithms and
machine learning algorithms in healthcare. Section 3 provides an up-to-date literature on seven key
applications. Finally, a conclusion is drawn.
2. Emerging Optimization Algorithms and Machine Learning Algorithms
When it comes to mathematical or engineering problems, optimization algorithms play an
important role because people desire to select the best solution (generally better solution) among
plenty of possible solutions based on some criteria. The difficulty of the optimization problem depends
on its nature and complexity. Solving convex optimization problems is generally less difficult than
non-convex problems because the local minimum must be a global solution and thus first-order
conditions are optimally sufficient conditions [141]. Multiobjective optimization problems (that often
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have multiple conflicting objectives) are more complex than single objective optimization problem.
A tradeoff solution or near optimal solution is sometimes being selected when the global optimal
solution is undetermined or requires huge computation power.
The overview of the algorithms and their applications in smart healthcare is provided in the
following subsections.
2.1. Optimization Algorithms
There are many types of optimization algorithms, for instance evolutionary optimization,
stochastic optimization, and combinatorial optimization. It is worth mentioning that an algorithm
can be a mixture of different types of optimization algorithms, depending on their nature and the
formulation of the problem. Readers interested in other optimization techniques are encouraged
to consult Bellman [142] for dynamic programming, Bertsekas [143] for gradient method, and
Glover et al. [144] for metaheuristics.
2.1.1. Evolutionary Optimization
Biological evolution is the inspiration of evolutionary optimization, also known as evolutionary
computation. The first idea of evolutionary computation was proposed in the 1950s [8,9]. Biologically,
there are many solutions for the population which is subjected to natural selection, breeding and
mutation. The population evolves in a way that leads to an increase of its suitability to the
environment (in the computational environment, the fitness function is used to measure this suitability).
Computationally, a set of candidate solutions is initialized and updated iteratively. For new iterations
(also known as generations), the less desired solutions will be removed according to the fitness values.
The effectiveness of evolutionary algorithms can be examined by the convergence analysis.
The classical steps for evolutionary algorithms have been summarized in [10] and are as follows:
(i) a population of candidate solutions is initialized, and each solution is encoded using alphabet of
cardinality; (ii) each solution is evaluated with a fitness value; (iii) new solutions are generated by
altering the existing solutions; (iv) each new solution is evaluated with a fitness value and inserted
into the population; (v) replace the solutions of population with new solutions; and (vi) return to (iii)
until reaching the maximum allowable time.
A problem solved by an evolutionary algorithm can be either single objective or multiobjective.
Multiobjective optimization deals with optimization problems involving more than one objective
function [12]. In this situation, the objective functions are conflicting. Thus, there exists many (could be
infinite) Pareto optimal solutions. If none of the objective functions can be enhanced in value without
scarifying other objective values, the solution is named non-dominated Pareto optimal solution.
For healthcare facility location-allocation in smart city (Hong Kong as an example) [13], four
objectives were considered: (i) maximization of the population accessibility; (ii) minimization of the
inequity of accessibility; (iii) minimization of the number of people beyond the threshold of travel
distance; and (iv) minimization of the cost of setting up any new public healthcare facility. The problem
is solved by a genetic algorithm (GA) modified to deal with multiple objectives. The cost of the mean
solution is 1.7050 × 106, the population out of coverage is reduced from 3.4413 × 106 to 3.1866 × 106,
the total accessibility is increased from 2.9633 × 107 to 5.8485 × 107 and inequity of accessibility is
reduced from 3.5915 × 106 to 3.1768 × 106.
Another GA based multiobjective optimization problem was formulated in partitioning the
healthcare system in Brazil [145]. Minimization of inter-microregion traveling, maximization of
population homogeneity and medical procedures are defined as objectives. The improvements in
the three objectives are 7.1% (2211 × 108 versus 2380 × 108), 23.5% (76,101 versus 99,537) and 7.8%
(1773 versus 1644), respectively.
Emergency services are critical for saving lives and, consequently, a modified artificial bee
colony algorithm was applied to solve the multiobjective optimization problem of emergency medical
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resources allocation [14]. It was important to optimization both the distances between patients and
first-aid institutions and available resources requirement.
GA and differential evolution (DE) were employed to deal with the multiobjective optimization
for the design of rectangular façade in common space of healthcare building [15]. The objectives were:
(i) minimizing the cost of façade construction; and (ii) maximizing the daylight performance. Results
indicated that GA achieved better performance in terms of convergence and hyper-volume, whereas
DE provided wider range of optimal solutions.
A home healthcare scheduling multiobjective optimization problem was considered to improve
the patients’ satisfaction [16]. Again, GA was utilized to solve the multiobjective optimization with
objectives travel cost, service cost and penalty cost. It was highlighted that home healthcare could
reduce the chances for patients’ admission to hospitals due to non-emergency healthcare issues and
thus relieved the workload of medical personnel.
A multiobjective optimization was illustrated in the healthcare facility planning of
location-allocation problem via particle swarm optimization [17]. The conflicting objectives are defined
as minimization of travelled distance taken from service seekers outside the facility coverage area and
maximization of the demand coverage.
2.1.2. Stochastic Optimization
There are many optimization problems that contain varying parameters, for instance, cost factor,
demand parameter and noise factor. These kinds of parameters should be modeled in the form
of random variables attributable to stochastic uncertainties. Trivial solutions include: (i) applying
parameter estimation to replace the unknown parameters (nevertheless, the performance of the system
is lowered); and (ii) online input correction of the system (this is generally time-consuming and
has increased costs) [18]. Stochastic optimization via introduction of stochastic parameters into the
optimization problem is a way out.
A summary of many techniques for stochastic optimization (for example, procedures of
iterative solution, approximate problem, stochastic approximation, stochastic gradient, non-convex
optimization, Laplace expansion of integrals, first order reliability method, regression and response
surface method, and Taylor expansion) is presented in [19].
Attributed to random parameters variation, the optimal solutions are insensitive and thus a
suitable deterministic substitute problem should be formulated. It is often found that the problem is
related to probability of success, probability of failure, or expectation. This results in a non-convex
optimization problem which is handled by approximation. There are two not uncommon categories of
deterministic substitute problems: (i) expected total cost minimization [19–21]; and (ii) reliability-based
optimization [22–24].
Recovery beds and operating rooms scheduling was formulated as a stochastic optimization
problem [25]. The randomness was from capacity of resources and undetermined in the duration of
surgery and recovery. For the objectives, authors have focused on the assignment and plan of surgery
and recovery respectively. An orthopedic surgery department was chosen as simulation environment.
Radiotherapy is often used as a treatment to kill or control malignant cells offered to cancer
patients. In [26], the management of facility in radiotherapy has been improved by introducing
stochastic optimization on the waiting time before the first treatment and its duration. The uncertainty
in this problem was defined as the arrival of patients and this follows a Poisson distribution.
Nurse scheduling problem has remained a great concern. A recent sample average approximation
based stochastic optimization algorithm was proposed to find the optimal solution in minimizing
the assignment cost [27]. There was randomness in the nurse preferences, medical demand
and hospitalization.
An excellent management is always sought for in emergency department which specializes
in acute care and emergency medicine. Sample average approximation was also employed to
optimize the expected waiting time of acute care patients and shift scheduling [28]. The simulation
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analysis has assumed that the patient arrivals into the emergency department obey inhomogeneous
Poisson distribution.
Patient scheduling has been optimally designed by minimizing the completion time of medical
treatments and waiting time of patients [29]. Since the service sequences and times are heterogeneous
and stochastic, respectively, it increases the complexity of the optimization problem. The Multiobjective
Tabu Search (MOTS) method was employed.
2.1.3. Combinatorial Optimization
Many real-world optimization problems are found to be exhaustive where the solution space
is composed of multiple solutions. Examples of such type of problems that are solved using
combinatorial optimization are minimum spanning tree problem [30] and travelling salesman
problem [31]. The solvers aim at finding optimal solution from a finite set of solutions. The feasible
solution should be reduced to discrete.
In general, combinatorial optimization problems can be solved by polynomial time algorithms
which have the running time bounded by a polynomial expression in the size of the input. Examples
include maximum matching in graph, arithmetic operations and selection sort sorting algorithm.
When it comes to public hospitals, the different surgeries taking place in an operating room can
be classified into: emergency, urgent and elective [32]. The corresponding waiting times for surgery
are immediate, up to a week or up to a few years. It is stressful and frustrated to wait for surgery,
especially for those who are classified as elective surgery patients. A combinatorial optimization
problem was formulated to solve the objectives of minimizing the number of patients waiting for
elective surgery and its cost, and it was solved using genetic algorithm [33].
In private healthcare industries or hospitals, the providers can charge significant differences in
price for the identical medical treatment. A report showed that, in United States, the price for an
appendectomy was between USD 1529 and USD 182,955 [34]. It is not always true that the quality
of service increases with the price and, therefore, in [35], a combinatorial optimization problem was
formulated to minimize the patient’s cost and maximize the providers’ quality.
Another problem is represented by home hospice care scheduling and staffing. It was analyzed
in [36] and it was concluded that there should be a balance between quality of hospice care and
available manpower. Therefore, the problem was formulated as maximization of the number of
patients serviced by medical personnel, while fulfilling the need of the patients.
Attention was drawn to the optimal plan for non-coplanar intensity modulated radiotherapy [37].
It could be characterized by three steps (i) iterative beam selection of solutions (i.e., non-coplanar beam
directions); (ii) finding beam trajectory via combinatorial optimization; and (iii) obtaining the optimal
non-coplanar intensity modulated radiotherapy plan.
Home care scheduling could be considered as a hierarchical based combinatorial optimization
problem [38]. An optimal route with minimal travelled distance was required between staffs offered
by medical service companies and patients at home. This is similar to the multiple traveling
salesman problem.
2.2. Machine Learning Algorithms
The term machine learning has a long history [146]. Its definition is as follows: the field of study
that gives computers the ability to learn without being explicitly programmed. Many real-world
problems can be modeled by machine learning algorithms. Some examples are: classification,
regression, clustering, dimensionality reduction, structured prediction, face detection, decision making,
speech recognition, signal de-noising, anomaly detection, deep learning and reinforcement learning.
Machine learning can be categorized into four types (i) un-supervised learning; (ii) supervised
learning; (iii) semi-supervised learning; and (iv) reinforcement learning. Fundamentally, none of the
data is labeled in type (i), the training/testing samples are labeled in type (ii) and there are many
Sustainability 2017, 9, 2309 6 of 23
unlabeled data and few labeled data in type (iii). The comparison of the first three aspects is illustrated
in Figure 1.Sustainability 2017, 9, 2309  6 of 24 
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The challenge that people are confronted with is handling massive amounts of data generated by
every entity in the world. Take the Internet as an example, over a billion of people are connected to
the Internet every day. As a result, these people generate tremendous data. Appropriate utilization of
data is valuable in terms of price and knowledge [147,148]. What we call data should make sense to
proceed any further with intelligent data analysis. More important, the limited computational power of
personal computer (even supercomputer) cannot solve all real-world problems. Data analytics should
remove and neglect some of the data to enjoy a finite and reasonable computation time. In addition,
efforts are majorly devoted to the more influencing applications to the society: healthcare, energy
crisis, education, food security, overfishing, environmental pollution, migration crisis, urbanization,
and water security.
2.2.1. Un-Supervised Learning
In reality, there exist many unlabeled data which can be intentional missing label or unintentional
missing label. The former data are usually labeled initially; one may remove the label and formulate the
problem as relation or correlation analysis between samples. The reasons for latter data are two-fold.
First, the staff may forget to enter the label by mistake. Second, it is possible that the data owner
company does not believe that the data are useful so that data collection managing is neglected.
Un-supervised learning deals with the problem of design of model to narrate the hidden
pattern and relationship of unlabeled data using machine learning algorithms. Typical methods
for unsupervised learning are un-supervised clustering and un-supervised anomaly detection.
Un-supervised clustering aims to organize similar unlabeled data into groups named clusters.
Therefore, the data within the same cluster have similar characteristic and are dissimilar to data
in other clusters. There are three basic techniques for clustering, proximity measure (similarity or
dissimilarity measure), criterion function for clustering evaluation, and algorithms for clustering. It can
be further divided into hierarchical clustering (divisive or agglomerative) [39], partitional clustering
(centroid, model based, graph theoretic, or spectral) [40] and Bayesian clustering (decision based or
non-parametric) [41].
It is curious if it is possible to influence the culture of staff of intensive care unit department
to improve the patient satisfactory and safety. Unsupervised clustering was performed to analyze
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the usual patterns among staff [42]. Results have concluded that we can recognize and group the
influencers in developing intervention to alter the culture.
Hidden infectious diseases are frightful because medical experts are generally not familiar with
their features. As a result, effective and reliable medical treatments are seldom available and further
research studies are necessary. A recent study aimed at identifying hidden infectious diseases based
on data retrieved from unlabeled social media messages [43].
Un-supervised anomaly detection is defined as the recognition of outliers, noise, deviations,
exceptions or novelties which comply with the majority of the unlabeled data. In healthcare,
medical errors [44], healthcare sensor faults [45], healthcare monitoring system [46], abnormal ECG
signal [47], anomalous behavior signs [48] and clinical pathway [49] are examples of anomaly detection.
The categories for anomalies are: (i) collective anomalies, a group of data points collectively facilitates
the anomaly detection; (ii) contextual anomalies, it is context specific, normally in the form of
time-series; and (iii) point anomalies, one instance is anomalous.
2.2.2. Supervised Learning
In machine learning, due to its application in classification and regression, a larger group of
researchers focused on supervised learning. The datasets contain individual paired data which have
input and output values. Generally, algorithms are selected to create inner relations based on the
training data and to generalize unseen data.
There are five general steps for supervised learning model: (i) data collection of training and
testing datasets; (ii) feature extraction; (iii) selection of machine learning algorithm; (iv) model
construction using the selected algorithm; and (v) algorithm evaluation and comparison to
other algorithms.
There exist packages for supervised learning in various programming languages such as MATLAB,
Java, C++, and Python which provide build-in functions. Because there are numerous practical
challenges, they cannot be simply treated as black-box (simply enter the input features). Some of the
difficulties are: large dimensionality of feature vectors [50], bias/variance dilemma [51], input and
output noise [52], large-scale training data [53], data heterogeneity [54], data redundancy [55] and
non-linearity among features [56].
Applications include but are not limited to prediction of virus-host infectious association [57],
human pose detection [58], virtual screening for hyperuricemia [59], speech recognition for remote
healthcare [60] and biomedical information retrieval [61]. Some commonly used classification
algorithms are nearest neighbors [62], discriminant analysis [63], decision trees [64], naïve Bayes
classifier [65], neural network [66] and support vector machine [67]. For regression algorithms, typical
examples are support vector regression [68], neural network [66], generalized linear models [69] and
linear and non-linear regression [70].
Authors would like to give more elaboration on support vector machine and deep neural network
which are believed to be more famous in supervised machine learning.
Many learning algorithms based on non-linear kernels require a kernel function K(xi,xj) well
defined for all pairs of xi and xj. However, the computation times will be significantly increased when
predicting the class for new data points. Thus, support vector machine (SVM) becomes more and
more popular which offers sparse solutions, the predictions for new data points depend only on the
kernel function evaluated at a subset of training data. Another characteristic of SVM is that it deals
with convex optimization problem so that any local solution is a global optimal solution. To solve the
convex optimization problem, the technique of Lagrange multipliers is adopted. Readers who are not
familiar with this are highly encouraged to review the concept in [149].
The recent deep neural network learning application Google DeepMind’s AlphaGo is in the
limelight [150]. Machine learning, which is popular worldwide, is defined as computers able to
learn from data to perform tasks such as prediction, clustering, classification, decision making and
dimensionality reduction. Compared with the human beings, computers are superior in computation
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power and can handle many complex problems. It is noted that the complete theoretical development
of the algorithms is out of scope of this paper. Generally speaking, deep neural network is an artificial
neural network with multiple hidden layers between input layers and output layers. It is trivial that it
is more prone to overfitting and more time-consuming for training. However, it takes more advantages
when handling complex problems with large dataset [151].
2.2.3. Semi-Supervised Learning
Semi-supervised learning is relatively young compared to supervised and un-supervised learning.
Chances are that there are many unlabeled data but only few labeled data are available. This is
the reason for the name semi-supervised as it lies between supervised learning (pairwise labeled
inputs and outputs) and un-supervised learning (completely unlabeled data). Nevertheless, it is
time consuming and costly to change unlabeled data into labeled data. For instance, web-based
health-related questions are seldom being answered by users [71], providing that community-based
question answering sites are important to address health information needs.
Here are the typical learning strategies of semi-supervised learning [72]. First, a supervised
learning algorithm that sets some learning rules for labeled data is selected. Then, the rules are
modified to include unlabeled data. The robustness of such approach depends on the reliability of
labeling, i.e., it has poor robustness if it has severe labeling error.
When constructing semi-supervised learning models, at least one of the following assumptions
is made: (i) Smoothness assumption is a concept that samples (in the forms of feature vector) which
are close to each other have a higher opportunity have the same output label as they share similar
characteristic in feature space [73]; (ii) The cluster assumption claims that the datasets have a tendency
to form clusters where samples in the same clusters have higher chance to be the same output label [74];
and (iii) Similar to the first assumption, but referring to clustering, manifold assumption means that
data lie on a low-dimensional manifold embedded in a higher-dimensional space [75]. It is noted that
manifold is a topological space that locally resembles Euclidean space near each point.
Many existing approaches for semi-supervised learning have been discussed. Typical examples
are graph-based model [76], self-training [77], co-training [78], generative model [79], low-density
separation [80], and heuristic model [81].
2.2.4. Reinforcement Learning
Reinforcement learning is related to agents trying to maximize the total reward under interaction
with uncertain and complex environment [152]. In the field of control and operation research, it is
also named approximate dynamic programming [153]. Differed from standard supervised learning,
reinforcement learning does not possess correct input/output pairs and sub-optimal actions.
Basically, two strategies are commonly used to solve reinforcement learning problems [154].
First, researchers aim at finding a good behavior in the environment via searching the space of
behaviors. Second, estimation of the utility of taking actions in states of the world is considered with
aid of dynamic programming and statistical techniques.
The lifelong function of dynamic treatment regimes was estimated using reinforcement
learning [155]. Testing datasets were retrieved from about 6000 patients of Acute Myeloid Leukemia.
The algorithm comprised of deep neural network and deep Q-learning which aimed at handling
heterogeneous high dimensional actions and states in practical problems.
A multi-agent system was proposed for continuous patient monitoring for improvement in
overall user (with poor motor skills or vision) experience [156]. To learn the behavior of user, the
reinforcement learning tracked the errors in the interface use and the actions of users. It is noted
that behavior consists of statistical interactions with the graphical user interface, whereas the action
consists of user preferences and choices.
Sustainability 2017, 9, 2309 9 of 23
A reinforcement learning based neuroprosthesis controller was trained to evaluate target-oriented
task performed using planar musculoskeletal human arm [157]. The results reflected that human
rewards are effective measures to train the controller.
When it comes to mobile health applications, medical video streaming via adaptive rate control
algorithm was studied [158]. Reinforcement learning was applied to fulfill the requirement of high
quality of service. The end-to-end delay was lower than the minimum requirement of 350 ms and
image quality was improved by 2.5 dB.
3. Smart Healthcare Applications
Since there are numerous applications in smart healthcare, this review only focuses on disease
diagnosis. Cardiovascular diseases, diabetes mellitus, Alzheimer’s disease and other forms of dementia
and tuberculosis are on the list of top 10 causes of annual global death in 2015. Table 1 summarizes
the mortality due to these diseases in 2000, 2005, 2010 and 2015 [159]. It can be seen that the first
three types of diseases increase, whereas the tuberculosis decreases from 2000 to 2015. The percentage
changes in 2000–2005, 2005–2010 and 2010–2015 in each type of disease are6.7%, 8.03%, and 6.4%;
19.9%, 17.7%, and 17.8%; 29.9%, 36.1%, and 33.7%; and −5.58%, −10.6%, and −2.34%, respectively.
These diseases led to more than 22 million deaths in 2015.
Table 1. Mortality due to cardiovascular diseases, diabetes mellitus, Alzheimer’s disease and other
forms of dementia, and tuberculosis in 2000, 2005, 2010 and 2015.
Disease
Deaths (’000) in Particular Year
2000 2005 2010 2015
Cardiovascular diseases 14,375 15,338 16,570 17,631
Diabetes mellitus 945 1133 1333 1570
Alzheimer’s disease and other forms of dementia 649 843 1147 1534
Tuberculosis 1666 1573 1406 1373
The optimization algorithms and machine learning approaches that have been utilized for smart
healthcare covering the diseases from Table 1 will be discussed in the following subsections.
3.1. Cardiovascular Diseases
Cardiovascular diseases are a group of disorders involving heart and blood vessels. Some
common conditions include atherosclerosis and may even result in stroke. Most of the risk factors of
cardiovascular diseases are related to human lifestyle and the corresponding percentages of factors
attributable to mortality are as follows: 40.6% for high blood pressure; 13.7% for smoking; 13.2%
for poor diet; 11.9% for insufficient physical activity; 8.8% for abnormal glucose levels; and the rest
for other factors [82]. Therefore, improving the eating habit and lifestyle is an effective measure for
preventing cardiovascular disease. The main principle of healthy lifestyle includes low-salt and low-fat
diet, regular exercising and quitting smoking [83].
Stroke is one kind of cardiovascular disease. A stroke will happen when there is an interruption
of the blood supply to brain. The common causes will be burst blood vessels in brain or a blockage by
a clot. This in turn cuts off the supply of oxygen and nutrients to brain cell, and causes damages to
the brain tissue. Hypertension is the most notable risk factor of stroke [84] and thus having a good
management of blood pressure will be a preventive measure of stoke.
The key priority for effective primary stroke prevention should be focusing on behavioral and
lifestyle risk factors, including smoking, unhealthy diet, sedentary lifestyle, and improper use of
alcohol [85]. Other than diet modification, engaging in physical activity for at least 30 min every day
will help to prevent stroke [86].
The surface electrocardiogram (ECG) is the most widely adopted means to record electrical
activity of the heart and for diagnosis of cardiovascular diseases [87]. Besides, ECG can be used for
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risk stratification and selection of optimal management for different types of cardiovascular diseases.
An alternative method, vectorcardiography is rarely used in clinical practice [88].
In [89], it was concluded that there are three types of features namely fiducial features (FF),
non-fiducial features (NFF) and hybrid features (HF). FF is defined as any feature that is related to the
characteristic points (P wave, QRS complex and T wave) of ECG signal, whereas NFF is the opposite of
FF. For HF, it has both FF and NFF. Table 2 shows some of the methodologies that have been proposed
for cardiovascular diseases classification [90–94] or ECG recognition [95–99].
Table 2. Summary of related works on cardiovascular diseases classification or heartbeat classification.
Work Diseases Methodology TF Ns
Performance (%)
Se Sp OA
[90] HC + Ca + MI + Hy + Dy LS; SVM NFF 65 / / 90.34
[91] HC + Ca RF; SVM FF 221 87 92 94
[92] HC + CHF CART FF 41 93.3 63.6 /
[93] HC + CHF + VT + AF FL; GA NFF 300 / / 93.34
[94] HC + CA + MI KNN NFF 207 99.7 98.5 98.5
[95] HB SKF; SVM HF 48 / / 98.3
[96] HB NN FF 17 / / 95
[97] HB CNN NFF 47 96.71 91.64 93.47
[98] HB NN; SVM NFF 48 98.91 97.85 98.91
[99] HB FCM FF 48 / / 81.21
AF = atrial fibrillation; Ca = cardiomyopathy; CART = classification and regression tree; CHF = congestive heart
failure; CNN = convolutional neural network; Dy = dysrhythmia; FCM = fuzzy c-means clustering; FL = fuzzy logic;
GA = genetic algorithm; HB = heartbeat; HC = healthy control; Hy = Hypertrophy; KNN = K-nearest neighbor;
LS = least-square; MI = myocardial infarction; NN = neural network; Ns = sample size; OA = overall accuracy;
RF = random forest; Se = sensitivity; SKF = switching Kalman filter; Sp = specificity; SVM = support vector machine;
TF = type of features; VT = ventricular tachyarrhtthmia.
Eleven machine learning or optimization algorithms have been applied in [90–99]. Different
algorithms may have their superiorities in particular application. The number of patients, Ns, is very
small compared to the number of cardiovascular diseases sufferers (more than 10 million). However, it
is difficult for researcher to tackle the problem of small sample size because the datasets are generally
retrieved from public domain (hospitals). It depends on the willingness of the policy of government
that the data from patients can be fully disclosed to public. The performances are good (>90%) in most
of the works, except [92,99].
3.2. Diabetes Mellitus
Diabetes mellitus, or simply called diabetes, is one of the serious epidemic diseases in the world.
Over 400 million people are living with diabetes [100]. It is expected that by 2035, the total number of
adults with diabetes would increase to 592 million [101]. Its subsequent macrovascular complications
could be fetal. Enormous financial burden is putting on diabetes related area. Many patients have to
rely on medication in their lifetimes to control diabetes.
There are two types of diabetes, insulin-dependent diabetes (or type 1 diabetes) and
noninsulin-dependent diabetes (or type 2). Generally speaking, most diabetes cases belong to type 2
as it is often onset in adulthood and caused by unhealthy lifestyle, improper diet and obesity [102].
These factors then cause a combined defect of insulin secretion and insulin resistance resulting in
different severity of diabetes.
Recently, there are many studies in diabetes mellitus via machine learning algorithms. The applications
are summarized in Table 3. The applications on diabetes are type 2 diabetes diagnosis [103–105],
prediction of fasting plasma glucose status [106], analysis of predictive power of hypertriglyceridemic
waist phenotype [107], detection of hypoglycemic episodes in children [108], prediction of
protein–protein interaction [109], prediction of vascular occlusion [110], prediction of development of
liver cancer for diabetes sufferers [111] and detection of microalbuminuria [112] related to diabetes.
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Table 3. Summary of related works on machine learning applications in diabetes mellitus.
Work Applications Methodology Ns Performance
[103] Diagnosis of type 2 diabetes RF; SVM 7913 Precision: 94.2%; Recall: 93.97%
[104] Diagnosis of type 2 diabetes DT; KNN; NBC LR;RF; SVM 300 average AUC = 98%
[105] Diagnosis of type 2 diabetes ACO; FL 768 Accuracy = 84.24%
[106] Predicting of fasting plasmaglucose status LR; NBC 4870 AUC (Female): 0.74; (Male): 0.68
[107]
Analysis of predictive power of
hypertriglyceridemic waist
phenotype for type 2 diabetes
LR; NBC 11,937
waist-to-hip ratio + triglyceride (men):
AUC = 0.653; rib-to-hip ratio +
triglyceride (women): AUC = 0.73
[108]
Detection of hypoglycemic
episodes for type 1
diabetes children
NN 16 Sensitivity = 78%; Specificity = 60%
[109] Prediction of type 2 diabetesrelated proteins SVM 1296 Accuracy = 78.2%
[110]
Prediction of peripheral
vascular occlusion in
type 2‘diabetes
SVM; WPS 33 Accuracy = 100%
[111] Predicting the development ofliver cancer in type 2 diabetes LR; NN 2060 Sensitivity = 75.7%; Specificity = 75.5%
[112] Detection microalbuminuria intype 2 diabetes FL; LR; PSO 200
Sensitivity = 95%; Specificity = 85%;
Accuracy = 92%
ACO = ant colony optimization; AUC = area under the curve; DT = decision tree; FL = fuzzy logic; KNN = k-nearest
neighbor; LR = logistic regression; NBC = Naive Bayes classifier; NN = neural network; PSO = particle swarm
optimization; RF = random forest; SVM = support vector machine; WPS = wolf pack search.
Similar to the cases in cardiovascular diseases (Table 2), there are 12 types of algorithms that
have been utilized for diabetes mellitus. The number of samples has an increase tendency, which
leads to more trustworthy results in evaluating the algorithms. It is still challenging (less than 80% in
performance) in the fields of prediction of fasting plasma glucose status, analysis of predictive power
of hypertriglyceridemic waist phenotype, detection of hypoglycemic episodes in children, prediction
of protein–protein interaction and prediction of development of liver cancer for diabetes sufferers.
3.3. Alzheimer’s Disease and Other Forms of Dementia
Dementia is a general term describing the decline in mental ability including memory and thinking
skills that affect the human daily living activities. Dementia is resulted from damages of brain cells
making them unable to communicate with each other [113]. Alzheimer’s disease is the most common
form of dementia, making around 60–80% of all cases. Some Alzheimer’s disease patients in final
stages may have lost basic bodily functions, including swallowing and moving their limbs. They will
need around-the-clock care and this puts a huge financial burden on the medical system and social
welfare department of government.
The number of dementia cases increases with aging. This leads to a huge concern among
healthcare professionals. Dementia, unlike other forms of chronic illness, has a higher prevalence
in developed countries. It is a pandemic disease that affects people in different regions. Moreover,
studies have found that people with metabolic syndromes like diabetes and obesity are at higher risk
of Alzheimer’s disease [114]. Therefore, Alzheimer’s disease and dementia will be one of the most
challenging non-communicable diseases to battle in this era.
Table 4 shows some studies in Alzheimer’s disease and other forms of dementia via machine
learning algorithms. The applications include diagnosis of Alzheimer’s disease [115,116], diagnosis
of dementias [117], and detection of Alzheimer’s disease related regions [118], prediction of mild
cognitive impairment patients for conversion to Alzheimer’s disease [119,120], detection of dissociable
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multivariate morphological patterns [121], diagnosis of both Alzheimer’s disease and mild cognitive
impairment [122] and identification of genes related to Alzheimer’s disease [125,126].
Table 4. Summary of related works on machine learning applications in Alzheimer’s disease and other
forms of dementias.
Work Applications Methodology Ns Performance
[115] Diagnosis of Alzheimer’s disease NBC; RF; RLO;RS; SVM 27 Accuracy = 97.14%
[116] Diagnosis of Alzheimer’s disease SVM 53 Accuracy = 96.23%
[117] Diagnosis of dementias LR; SVM 29 Accuracy = 93%
[118] Detection of Alzheimer’s diseaserelated regions SVM 126 Accuracy = 92.36%
[119]
Predicting mild cognitive
impairment patients for
conversion to Alzheimer’s disease
LDS 164 AUC = 0.7661
[120]
Predicting mild cognitive
impairment patients for
conversion to Alzheimer’s disease
GA; SVM 458 Sensitivity = 76.92%; Specificity = 73.23%;Accuracy = 75%
[121]
Identification of dissociable
multivariate
morphological patterns
LC 801 AUC = 0.93
[122]
Identification for Alzheimer’s
disease and mild
cognitive impairment
EM; SVM 338
Alzheimer’s disease: sensitivity = 84.86%,
specificity = 91.69%, accuracy = 88.73%;
Mild cognitive impairment: sensitivity = 79.07%,
specificity = 82.7%, accuracy = 80.91%
[123]
Identification for Alzheimer’s
disease and mild
cognitive impairment
DCNN 900
Alzheimer’s disease: sensitivity = 98.89%,
specificity = 97.78%, accuracy = 98.33%;
Mild cognitive impairment: sensitivity = 92.23%,
specificity = 91.11%, accuracy = 92.12%
[124]
Identification for Alzheimer’s
disease and mild
cognitive impairment
DCNN 142
Alzheimer’s disease: sensitivity = 85%, specificity
= 82%, accuracy = 85%; Mild cognitive impairment:
sensitivity = 84%, specificity = 81%, accuracy = 85%
[125] Identification of genes related toAlzheimer’s disease DT; QAR 33 90 genes are related to Alzheimer’s disease
[126] Identification of genes related toAlzheimer’s disease ELM; RF; SVM 31
Sensitivity= 78.77%; Specificity= 83.1%;
Accuracy = 74.67%
DCNN = deep convolutional neural network; DT = decision tree; ELM = extreme learning machine; EM = expectation
maximization; GA = genetic algorithm; LC = lasso classification; LDS = low density separation; LR = logistic
regression; NBC = Naive Bayes classifier; QAR = quantitative association rules; RF = random forest; RLO = random
linear oracle; RS = random subspace; SVM = support vector machine.
Fourteen different algorithms were employed in [115–126]. The datasets of Alzheimer’s disease
and other forms of dementia have relatively small sample size. Three applications, prediction of mild
cognitive impairment patients for conversion to Alzheimer’s disease [119,120], prediction of mild
cognitive impairment [122–124] and identification of genes related to Alzheimer’s disease [125,126]
are required to have further improvement3.4. Tuberculosis
Tuberculosis (TB) was a lethal infectious disease caused by bacteria mycobacterium tuberculosis
that usually attacks the lung. The transmission way is mainly through the air, and thus TB is actively
spread among the community. It was a public health concern in early 19th century. With the
development of drugs and hygiene awareness, the incidence rate has declined slowly since the
1990s [127].
People in poor and undeveloped countries are more vulnerable to TB because of poor
environmental conditions, food insecurity, and inconvenient access to healthcare services [127].
Early detection is important for TB control. Without proper diagnosis, infected people are the
major source of infection in the community [128]. It is estimated that about 3 million people remain
undiagnosed or are not notified [129].
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Intensive research was carried out on prevention and fighting against TB [130]. TB control is
crucial with effective surveillance system for instantaneous reporting. With the development of science
and technology, it is hoped that TB would not be a major public health issue in next generation.
Smart healthcare applications on tuberculosis include identification of drug resistance-associated
mutations [131], detection of tuberculosis [132–135], detection of multidrug resistance tuberculosis [136],
prediction of treatment failure [137], identification between tuberculosis and human immunodeficiency
virus (HIV) [138], predicting recent transmission of tuberculosis [139] and detection of smear-negative
pulmonary tuberculosis [140]. These are summarized in Table 5. Similar findings can be observed in
applications in tuberculosis. There are 12 types of algorithms in seven applications in tuberculosis and the
sample sizes of datasets are limited. The performance of two of the works [133,139] can be improved in the
future. Other algorithms can be applied to obtain a favorable performance (>90%).
Table 5. Summary of related works on machine learning applications in tuberculosis.
Work Applications Methodology Ns Performance
[131]
Identification of drug
resistance-associated
mutations in tuberculosis
LMM; LR; MOSS 144 Accuracy of over 90% in selected 9 drugs
[132] Detection of tuberculosis KNN; SVM 917; 869; 850 KNN: AUC = 0.84; 0.78; 0.82SVM: AUC = 0.88; 0.79; 0.85
[133] Detection of tuberculosis CNN 4701 Accuracy = 62.07%
[134] Detection of tuberculosis CNN 138;662 Accuracy = 82.6%;92.6% AUC = 84.7%; 92.6%
[135] Detection of tuberculosis SVM 150 Accuracy = 96.68%
[136] Detection of multidrugresistance tuberculosis NN 280 Sensitivity = 95.1%; Specificity = 85%
[137] Prediction of tuberculosistreatment failure Xpert; Response5 153
Sensitivity = 83–100%;
Specificity = 26–100%
[138] Identification betweentuberculosis and HIV Filtering 54 Accuracy = 79–93%
[139] Predicting recenttransmission of tuberculosis LR 1552 Sensitivity = 53%; Specificity = 67%
[140] Detection of smear-negativepulmonary tuberculosis MLP 136
Sensitivity = 100%; Specificity = 80%;
Accuracy = 88%; AUC = 91.8%
CNN = convolutional neural network; KNN = k-nearest neighbor; LMM = linear mixed model; LR = logistic
regression; MLP = multilayer perception; MOSS = mode oriented stochastic search; NN = neural network;
SVM = support vector machine.
4. Challenges in Smart Healthcare
For the transition of healthcare to smart healthcare, numerous challenges are normally
encountered and research is still ongoing. In the following subsections, privacy, pilot studies and real
project, communication between data scientist and medical personnel, no free lunch theorem and
increase short-term to medium-term expenditure are discussed.
4.1. Privacy
Medical data contain meaningful information for modeling and analysis, which ultimately can
improve medical practice and research. The privacy must be protected from misuse and violation
so that patients and medical institutions will agree to release and share the data. The increase in
the data availability will improve the quality of healthcare [160]. A report has stated that about 60%
of patients realize that the wide-ranging employment of electronic health record will lead to more
personal information being stolen or lost and about half of patients think that the privacy of medical
data is not protected [161].
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Ideally, medical data should be accessible to authorized parties or public institutions only if security
and privacy are guaranteed. More important, researchers need medical data for carrying out data analysis,
statistical analysis and machine learning applications. Common privacy-preserving methods include
disclosure control [162,163], output perturbation [164,165] and anonymization [166,167].
It is hoped that, in the future, the shared datasets for medical applications (especially disease
diagnosis) will be increased in sample size. The key elements will be medical data privacy and the
government policies.
4.2. Pilot Studies and Real Projects
Since, in the long run, they reduce the risk of non-professional project deployment, pilot projects
are important and they help to select the appropriate risk mitigation strategies and application
directions. There is an increasing tendency to carry out pilot studies [168].
Professionals gain experience and intuition to improve the protocol design, algorithms, and
hardware design of smart healthcare. However, in reality, only a few companies and researchers may
take part in real projects in healthcare. Most researchers fail to learn from the experience since it is not
uncommon that there are no timely publications, reports and feedbacks provided by the pilot projects.
Usually, the projects are target-oriented [169]. However, chances are that there exist alternate solutions
that are cost-effective which may replace the current solution.
It is highly encouraged that before the technology platforms are adopted, various algorithms and
technologies that are tested and selected for adoption should be consolidated into technical reports
and papers, and shared to the public.
Economically, it is desired that governments can support basic research and innovation [170].
Regarding the private sectors, they take up the responsible for the commercial and applied research
since they are keen on market needs and demands.
For the selection of the policy tool, the features of basic research are essential. If there is a
large-scale and highly focused project, conduct of research or direct government support is reliable to
maintain a good project management with numerous researchers and staffs [171].
The effectiveness in research, innovation and development will be increased if government serves
as long-term investor. The time lag between basic research and real deployment commercially can be
large. Here are two examples for the benefit of long-term investment. The Internet revolution in the
1990s was the results of long-term investment covering twenty years [172]. The second example is that
the biotechnology commercialization was facilitated by the research findings in the 1950s [173].
4.3. Communication between Data Scientists and Medical Personnel
Data scientists generally lack sufficient medical knowledge and they require medical experts.
Similar situation happens for medical personnel. When data scientists would like to enter the medical
institutions, medical personnel and management teams often refuse [174]. From the data scientists’
perspective, medical data are useful for statistical analysis, prediction, classification and knowledge
discovery. From medical personnel perspective, they are used to diagnose patients via their medical
knowledge and rarely rely on the decision generated by machines.
Medical workers may argue that smart healthcare via machine learning and optimization
algorithms has a conflict of interest with them; however, this is not the case [175]. First, most of
the countries are suffering from a shortage of medical personnel and the medical shortage will become
more accentuated. Second, smart healthcare is mainly targeting routine works so that medical workers
can spend more time on professional consultation and surgery activities. Third, medical workers
will earn a higher social status and better job satisfaction because patients are more satisfied with the
medical services.
Both data scientists and medical personnel should make a step forward to see what the best
collaboration method is. The ultimate goal is to improve the quality of life.
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4.4. No-Free Lunch Theorem
However, it can be seen that there are numerous approaches in different machine learning
application in smart healthcare. There is a “No free lunch” theorem in machine learning which says
that no unique algorithm works best for every application [176]. As a result, when people design
algorithm for smart healthcare application, the analysis becomes tedious as one should go through
many algorithms and select the one with best performance. An important knowhow is to only try
appropriate algorithms for the problem. For instance, clustering algorithms seem inappropriate in
solving classification problems.
Deep learning has gained popularity in recent years, attributable to its superiority in solving
complex problem. However, it is reminded that deep learning is not always the best or necessary for
all problems. It depends on the complexity of the problem, available amount of data, computational
power and training time [177].
4.5. Increase Short-Term to Medium-Term Expenditure
Authors would like to emphasis that owing to the fact that machine learning in smart healthcare
is still young, government and institutions should spend more money as short-term to medium-term
expenditure. Many applications are only in initial stage where data collection, feature extraction,
and methodology are key criteria for successful deployment.
Ultimately, the smart healthcare applications will benefit human beings by increase of human life
expectancy, early disease examination, ambient assisted living, patient monitoring, etc. As a result,
we are in a sense making profit in the long-term using machine learning.
5. Conclusions
This review has provided an up-to-date literature on emerging machine learning algorithms,
optimization algorithms and applications in smart healthcare. Important challenges, including privacy,
pilot studies and real project and communication between data analytics and medical staffs, have
been discussed. These challenges are essential for the breakthrough of smart healthcare; otherwise,
the wide adoption of machine learning and optimization algorithms in real deployment is difficult to
succeed. To conclude, it is believed that human beings will enjoy more and more smart healthcare
applications in the coming decades. It is worth ensuring the health services are financially viable and
environmentally sustainable to safeguard the future health of our patients and the health services
availability in the future.
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